These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 678164)

  • 1. [Anti-hypertensive effect of intravenous verapamil in rats with experimental arterial hypertension].
    Vichi FL; Mazotti L; Capucci de Oliveira AF; Dráusio Martins J; Bernardes J
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():31-4. PubMed ID: 678164
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of verapamil in arterial hypertension].
    Carrasco RM; Luna RL; Rocha MC
    Arq Bras Cardiol; 1979 Mar; 32(3):207-11. PubMed ID: 475607
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of verapamil on cardio- and hemodynamics in rats with various models of hypertension].
    Spasov AA; Gurbanov KG; Seredintseva NV; Paperno AA
    Eksp Klin Farmakol; 1997; 60(3):30-3. PubMed ID: 9324394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Verapamil in the hypertensive crisis].
    Chamma Neto M; Pinto MJ; Rojas RI; Santos LM; Glitz T; Blume Ldo R; Quintino E; Michelotto PV; Maranhão MF; Sobrinho MI
    Arq Bras Cardiol; 1985 Feb; 44(2):135-7. PubMed ID: 3910001
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats.
    Karasawa A; Kubo K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical use of verapamil in hypertensive crisis].
    Gushi N; Mateos DA; Magaldi JB
    Arq Bras Cardiol; 1976 Feb; 29(1):67-74. PubMed ID: 779727
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of verapamil on arterial blood pressure and heart rate in awake animals with neurogenic and renal hypertension].
    Vasques EC; Mill JG; Moysés MR; da Silva FD; da Costa MB; Caldas JG; Cabral Ade M; Vassalo DV
    Arq Bras Cardiol; 1982 Aug; 39(2):99-103. PubMed ID: 7171334
    [No Abstract]   [Full Text] [Related]  

  • 8. [Calcium antagonists in the treatment of chronic arterial hypertension and hypertensive crisis].
    Brandt D
    Wien Med Wochenschr; 1983 Mar; 133(6):131-5. PubMed ID: 6134398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of slow-release verapamil in relation to plasma concentration in aged hypertensives. A study with continuous monitoring of arterial pressure and electrocardiogram].
    Canonico V; Bonaduce D; De Caprio L; Nicolino A; Forgione L; Petretta M; Rengo F
    G Ital Cardiol; 1990 Oct; 20(10):924-32. PubMed ID: 2090531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verapamil in cardiology.
    Krikler D
    Eur J Cardiol; 1974 Aug; 2(1):3-10. PubMed ID: 4153535
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental models of the use of calcium antagonists in arterial hypertension].
    Vasquez EC; Cabral AM; Moysés MR; Mill JG
    Arq Bras Cardiol; 1986 Apr; 46(4):245-50. PubMed ID: 3827668
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of the effect of verapamil in hypertensive patients].
    Gelman A; de Albuquerque EM; Reynaldo Stella S; Draibe SA; Ajzen H
    Arq Bras Cardiol; 1983 Jan; 40(1):69-71. PubMed ID: 6351814
    [No Abstract]   [Full Text] [Related]  

  • 13. On the mechanism of the anti-hypertensive effect of Ca++-blockers.
    Marmo E
    Res Commun Chem Pathol Pharmacol; 1986 Jan; 51(1):59-64. PubMed ID: 3952371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
    Al-Waili NS; Hasan NA
    Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Behavior of the blood pressure curve during the ergometric stress test, in treated and non-treated hypertensive patients].
    Carrasco RM; da Rocha MM; Luna RL
    Arq Bras Cardiol; 1981 Mar; 36 Suppl 1():24-32. PubMed ID: 7325860
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationships between verapamil plasma concentrations and its antihypertensive action.
    Gonzalez-Gomez A; Cires Pujols M; Gamio Capestany F; Rodriguez de la Vega A; Garcia-Barreto D
    Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):453-60. PubMed ID: 3198301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive properties of the novel calcium antagonist (1S,2S)-2-[2-[[3-(2-benzimidazolyl)propyl]methylamino] ethyl]-6- fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride in rat models of hypertension. Comparison with verapamil.
    Hefti F; Clozel JP; Osterrieder W
    Arzneimittelforschung; 1990 Apr; 40(4):417-21. PubMed ID: 2357242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Verapamil in the treatment of hypertensive emergencies].
    Carvalho Mde A; Osterne EC; de Alencar JE; da Fonseca AA; de Melo Junior MG; Aloan L; Carneiro RD
    Arq Bras Cardiol; 1981 Mar; 36 Suppl 1():55-7. PubMed ID: 7325866
    [No Abstract]   [Full Text] [Related]  

  • 19. Concentration/effect relationship and enantioselective analysis of verapamil in hypertensive patients.
    Harder S; Thürmann P; Siewert M; Blume H; Rietbrock N; vander Kleijn J; Gierend M
    J Cardiovasc Pharmacol; 1992 May; 19(5):665-9. PubMed ID: 1381762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous infusion of verapamil in patients of severe hypertension.
    Verma SK; Dosi R; Kaushik SK; Bordia A
    J Postgrad Med; 1990 Jan; 36(1):5-8. PubMed ID: 2097358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.